Showing 4,141 - 4,160 results of 6,719 for search '"Diabetes"', query time: 0.08s Refine Results
  1. 4141
  2. 4142

    Choosing between GLP-1 Receptor Agonists and DPP-4 Inhibitors: A Pharmacological Perspective by Dominique Xavier Brown, Marc Evans

    Published 2012-01-01
    “…In recent years the incretin therapies have provided a new treatment option for patients with type 2 diabetes mellitus (T2DM). The incretin therapies focus on the increasing levels of the two incretin hormones, glucagon-like peptide 1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP). …”
    Get full text
    Article
  3. 4143
  4. 4144

    Analysis of Risk Factors for Death of Covid-19 Patients at Undata Hospital Palu by Nur Afni, Sri Rahayu

    Published 2022-07-01
    “…Patients with comorbid are above 45 years on average. Diabetes and heart disease are risk factors for death from COVID-19 because those with diabetes have a 4.384 times greater risk of dying from Covid-19 than patients without diabetes.  …”
    Get full text
    Article
  5. 4145

    Euglycemic Ketoacidosis in a Patient with Metastatic Non-Small-Cell Lung Adenocarcinoma and Concomitant Pulmonary Embolism by Robert Sean O’Neill, Lauren Tyack, Mary Freeman, Hussein Soudy Hussein

    Published 2020-01-01
    “…We describe a case of euglycemic ketoacidosis in a patient with type 2 diabetes mellitus in the context of empagliflozin use after a recent diagnosis of metastatic lung adenocarcinoma. …”
    Get full text
    Article
  6. 4146
  7. 4147

    A Case of Persistent Hypoglycemia: Emphasizing the Role of Kidneys by Praveen Govindaraju, Mohammed Fahad Khan, Rohan Augustine, Hebri Sudarshan Ballal

    Published 2024-04-01
    “…Abstract Hypoglycemia is an important cause of morbidity and mortality in patients with diabetes mellitus. However, hypoglycemia in patients without diabetes warrants extensive clinical and biochemical evaluations. …”
    Get full text
    Article
  8. 4148
  9. 4149

    PPARγ Agonist Rosiglitazone Suppresses Renal mPGES-1/PGE2 Pathway in db/db Mice by Ying Sun, Zhanjun Jia, Gang Liu, Li Zhou, Mi Liu, Baoxue Yang, Tianxin Yang

    Published 2013-01-01
    “…Evidence had shown the detrimental effect of prostaglandin (PG) E2 in diabetic nephropathy (DN) of STZ-induced type-1 diabetes but its role in the development of DN of type-2 diabetes remains uncertain. …”
    Get full text
    Article
  10. 4150

    Common Risk Factors of Myocardial Infarction and Some Socio Demographic Characteristics in Sulaimani City by Bayan Omar Sharif, Samir Y. Lafi

    Published 2022-01-01
    “…Hypertension accounted (61.2%), dyslipidemia (39.4%), and diabetes (20%) of the subjects. A positive first-degree history of classical MI risk factor of the participants was (54.5%, 39.2% and 28.4%) for hypertension, heart attack and diabetes, respectively. (98.2%) of the selected patients no eating fish. (56.4%, 58.8%) of them were not eating daily fruit and vegetable respectively.  …”
    Get full text
    Article
  11. 4151

    Elevated and Correlated Expressions of miR-24, miR-30d, miR-146a, and SFRP-4 in Human Abdominal Adipose Tissue Play a Role in Adiposity and Insulin Resistance by Yury O. Nunez Lopez, Gabriella Garufi, Magdalena Pasarica, Attila A. Seyhan

    Published 2018-01-01
    “…Abdominal adipose tissue (AbdAT) levels of thirteen microRNAs (miRNAs), SFRP4, and VEGF in lean nondiabetic subjects (n=7), subjects with obesity (n=5), and subjects with obesity and type 2 diabetes (T2DM) (n=5) were measured by qPCR. Insulin sensitivity was measured by the euglycemic-hyperinsulinemic clamp. …”
    Get full text
    Article
  12. 4152

    Differences in metabolic characteristics between Metabolically Healthy Obesity (MHO) and Metabolically Unhealthy Obesity (MUO) in weight reduction therapy by Shiori Kawai, Hajime Yamakage, Kazuhiko Kotani, Mitsuhiko Noda, Noriko Satoh-Asahara, Koshi Hashimoto

    Published 2023-12-01
    “…Metabolically Healthy Obesity (MHO) is generally recognized as the absence of any metabolic disorders and cardiovascular diseases, including type 2 diabetes, dyslipidemia, and hypertension, in obese individuals; however, it is not clearly defined. …”
    Get full text
    Article
  13. 4153
  14. 4154

    Vida Saludable: Cuidándose de la cabeza a los pies by Jennifer Hillan, Emily Minton

    Published 2011-02-01
    “…Si usted padece de diabetes, ponga especial atención a su piel, sus ojos, sus dientes, sus encías y sus pies. …”
    Get full text
    Article
  15. 4155
  16. 4156
  17. 4157

    Risk factors for fluorouracil-induced cardiotoxicity in patients with gastrointestinal tumor by Yuting Wu, Chen Lv, Jindong Li, Ying Ma, Xiaoli Zhu

    Published 2025-02-01
    “…The occurrence of fluorouracil-induced cardiotoxicity was higher in patients with hypertension, hyperlipidemia, diabetes mellitus, older age, those treated with capecitabine, and combined radiotherapy. …”
    Get full text
    Article
  18. 4158

    Acute Hyperglycemia Due to Topical Corticosteroid Administration by Laura Y. Sue, Anna Milanesi

    Published 2019-01-01
    “…This case highlights the potentially detrimental effect of topical corticosteroid use in patients with diabetes.…”
    Get full text
    Article
  19. 4159

    The Role of Insulin, Insulin Growth Factor, and Insulin-Degrading Enzyme in Brain Aging and Alzheimer's Disease by Claude Messier, Kevin Teutenberg

    Published 2005-01-01
    “…Most brain insulin comes from the pancreas and is taken up by the brain by what appears to be a receptor-based carrier. Type 2 diabetes animal models associated with insulin resistance show reduced insulin brain uptake and content. …”
    Get full text
    Article
  20. 4160

    Physiological and pathophysiological actions of insulin in the liver by Naoto Kubota, Tetsuya Kubota, Takashi Kadowaki

    Published 2025-02-01
    “…Impaired insulin receptor signaling can cause hepatic insulin resistance and lead to type 2 diabetes. In the present study, we focus on a concept called “selective insulin resistance,” which has received increasing attention recently: the frequent coexistence of hyperglycemia and hepatic steatosis in people with type 2 diabetes and obesity suggests that it is possible for the insulin signaling regulating gluconeogenesis to be impaired even while that regulating lipogenesis is preserved, suggestive of selective insulin resistance. …”
    Get full text
    Article